CareDx

CareDx

Innovative noninvasive testing solutions enhancing transplant patient outcomes throughout their journey.

  • Edit

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth54 %9 %(13 %)19 %11 %15 %13 %
EBITDA0000000000000000000000000000
% EBITDA margin(10 %)(24 %)5 %(39 %)9 %14 %18 %
Profit0000000000000000000000000000
% profit margin(10 %)(24 %)(68 %)16 %(5 %)2 %7 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue26 %28 %29 %22 %---

Source: Company filings or news article, Equity research estimates

More about CareDx
Made with AI
Edit

CareDx is a healthcare company focused on improving outcomes for transplant patients through innovative, noninvasive testing solutions and services. The company operates in the transplant care market, providing a range of products and services designed to support patients, caregivers, and healthcare providers. CareDx's offerings include kidney transplant services, next-generation HLA typing for organ matching, and digital transplant administration solutions. Additionally, the company collaborates with biopharma partners to accelerate clinical development through its pharma services. CareDx generates revenue by offering these specialized testing and management solutions, which are critical for the ongoing care and monitoring of transplant patients. The company's business model is centered around providing comprehensive, patient-centric care that spans the entire transplant journey, from pre-transplant diagnostics to post-transplant monitoring and support. CareDx serves a diverse client base, including transplant patients, caregivers, healthcare providers, and biopharma companies. The company's innovative approach and commitment to personalized care make it a leader in the transplant care industry.

Keywords: transplant care, noninvasive testing, kidney transplant, HLA typing, digital solutions, patient monitoring, biopharma services, clinical development, personalized care, healthcare innovation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by CareDx

Edit
Miromatrix Medical
ACQUISITION by United Therapeutics Oct 2023
Allenex
ACQUISITION by CareDx Dec 2015
OTTR Chronic Care Solutions
ACQUISITION by CareDx Apr 2019
MediGO
ACQUISITION by CareDx Jul 2023
MedActionPlan
ACQUISITION by CareDx Nov 2021